Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children

被引:1
作者
Erazmus, Michal [1 ]
Ruminska, Malgorzata [1 ]
Witkowska-Sedek, Ewelina [1 ]
Kucharska, Anna M. [1 ]
Stelmaszczyk-Emmel, Anna [2 ]
Majcher, Anna [1 ]
Pyrzak, Beata [1 ]
机构
[1] Med Univ Warsaw, Dept Paediat & Endocrinol, Warsaw, Poland
[2] Med Univ Warsaw, Dept Lab Diagnost & Clin Immunol Dev Age, Warsaw, Poland
关键词
sRANKL; OPG; sRANKL ratio; cardiovascular risk factors; obesity; children; LOW SERUM-LEVELS; INSULIN-RESISTANCE; RANK LIGAND; URIC-ACID; VASCULAR CALCIFICATION; METABOLIC SYNDROME; RISK-FACTORS; B LIGAND; OSTEOPROTEGERIN; ATHEROSCLEROSIS;
D O I
10.3389/fendo.2022.963467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionChildhood obesity contributes to the development of cardiovascular diseases. The molecular pathway - receptor activator of nuclear factor-kappa beta ligand (RANKL), its receptor RANK and osteoprotegerin (OPG) - takes part not only in bone metabolism but is also involved in the atherosclerosis process. RANKL stimulates osteogenic differentiation and calcification of vascular smooth cells. The associations between the OPG-sRANKL system and various cardiovascular risk factors were displayed. We aimed to evaluate the relationships between serum sRANKL (soluble RANKL) levels and the OPG/sRANKL ratio with cardiometabolic risk factors in overweight and obese children. Material and methodsThe study included 70 children with overweight and obesity (mean age 13.0 +/- 2.8) and 35 age-matched normal weight, healthy peers as a control group. In all patients, anthropometric measurements and laboratory tests were performed. Additionally, an oral glucose tolerance test (OGTT) was made only in overweight and obese children. Atherogenic and insulin resistance indices were calculated. ResultsOverweight and obese children had lower sRANKL levels compared to the control group (median 276.95 vs 325.90, p=0.011), and consequently a higher OPG/sRANKL ratio (0.02 vs 0.01, p = 0.013). The studied children in the lowest quartile of sRANKL levels had higher body weight, Body Mass Index, waist circumference and increased glucose and insulin levels 60 minutes after OGTT and higher uric acid values compared to children in the highest quartile. In multivariable linear regression analysis sRANKL negatively correlated only with uric acid (beta = - 0.508, p = 0.041). No association was found for the OPG/sRANKL ratio. ConclusionExcess fat mass seems to alter the OPG/RANKL ratio mainly by reducing serum sRANKL levels. The correlation between sRANKL and uric acid may suggest a contribution of the OPG-sRANKL system in the cardiometabolic process, but that observation should be confirmed in future studies.
引用
收藏
页数:10
相关论文
共 60 条
[41]  
Perez Elizabeth Solis, 2017, BMC Obes, V4, P25, DOI 10.1186/s40608-017-0160-6
[42]   Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill Patients [J].
Puengel, Tobias ;
Weber, Beate ;
Wirtz, Theresa H. ;
Buendgens, Lukas ;
Loosen, Sven H. ;
Geisler, Lukas ;
ozdirik, Burcin ;
Hamesch, Karim ;
Jhaisha, Samira Abu ;
Brozat, Jonathan F. ;
Hohlstein, Philipp ;
Eisert, Albrecht ;
Yagmur, Eray ;
Trautwein, Christian ;
Tacke, Frank ;
Koch, Alexander .
DIAGNOSTICS, 2022, 12 (01)
[43]  
Rafieian-Kopaei M, 2014, INT J PREVENTIVE MED, V5, P927
[44]   The Role of Osteoprotegerin and Its Ligands in Vascular Function [J].
Rochette, Luc ;
Meloux, Alexandre ;
Rigal, Eve ;
Zeller, Marianne ;
Cottin, Yves ;
Vergely, Catherine .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
[45]  
Ruminska M., 2021, AMS, DOI [10.5114/aoms/140394, DOI 10.5114/AOMS/140394]
[46]   Enhanced T-cell expression of RANK ligand in acute coronary syndrome -: Possible role in plaque destabilization [J].
Sandberg, WJ ;
Yndestad, A ;
Oie, E ;
Smith, C ;
Ueland, T ;
Ovchinnikova, O ;
Robertson, AKL ;
Müller, F ;
Semb, AG ;
Scholz, H ;
Andreassen, AK ;
Gullestad, L ;
Damås, JK ;
Froland, SS ;
Hansson, GK ;
Halvorsen, B ;
Aukrust, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (04) :857-863
[47]   Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men [J].
Schoppet, M ;
Schaefer, JR ;
Hofbauer, LC .
CIRCULATION, 2003, 107 (11) :E76-E76
[48]   Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events A Nested Case-Control Approach in the Prospective EPIC-Norfolk Population Study 1993-2003 [J].
Semb, Anne G. ;
Ueland, Thor ;
Aukrust, Pal ;
Wareham, Nicholas J. ;
Luben, Robert ;
Gullestad, Lars ;
Kastelein, John J. P. ;
Khaw, Kay-Tee ;
Boekholdt, S. Matthijs .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (06) :975-980
[49]   sRANKL and its correlation with metabolic syndrome parameters in children [J].
Serrano-Pina, Rodrigo ;
Liliana Trujillo-Guiza, Martha ;
Scougall Vilchis, Rogelio J. ;
Layton-Tovar, Cristian F. ;
Mendieta-Zeron, Hugo .
INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2018, 28 (06) :633-640
[50]  
SLAUGHTER MH, 1988, HUM BIOL, V60, P709